{"transactions":[{"id":4615928,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":35580,"kind":"person","name":"Cao Sean Wuxiong","position":1,"cik":"0002109966","reported_name":"Cao Sean Wuxiong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Bus. Development Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-11T20:30:14.000Z","date":"2026-09-09","kind":"sale","planned":false,"acquired":false,"shares":107978,"price":0.74,"value":79903.72,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person sold 46,947 ADSs representing approximately 107,978 ordinary shares in connection with the partial vesting of a restricted stock unit award on September 3, 2026, solely to satisfy tax withholding obligations incurred in connection with the vesting."},{"field":"shares","element":"transactionShares","label":"F3","text":"Reported securities are represented by 46,947 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reported sales price represents the converted sales price of the ADSs of $1.6908."}],"balance_after":266467,"source":{"system":"sec-edgar","filing":"0002109966-26-000008","document":"form4-09112026_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2109966/000210996626000008/form4-09112026_040901.xml","form_type":"4"}},{"id":3570572,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":35580,"kind":"person","name":"Cao Sean Wuxiong","position":1,"cik":"0002109966","reported_name":"Cao Sean Wuxiong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Bus. Development Officer"}}],"security":"Restricted Share Units","published_at":"2026-09-08T21:51:01.000Z","date":"2026-09-03","kind":"exercise","planned":false,"acquired":false,"shares":45320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On June 22, 2026, the Reporting Person was granted 181,280 RSUs.  The RSUs vested or shall vest over four years, with one-fourth vesting on September 3, 2026 and the balance vesting ratably over the subsequent 12 quarters on the third day of each third month."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On June 22, 2026, the Reporting Person was granted 181,280 RSUs.  The RSUs vested or shall vest over four years, with one-fourth vesting on September 3, 2026 and the balance vesting ratably over the subsequent 12 quarters on the third day of each third month."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."}],"balance_after":135960,"derivative":{"underlying":"Ordinary Shares","underlying_shares":45320},"source":{"system":"sec-edgar","filing":"0002109966-26-000006","document":"form4-09082026_090957.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2109966/000210996626000006/form4-09082026_090957.xml","form_type":"4"}},{"id":3570571,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":35580,"kind":"person","name":"Cao Sean Wuxiong","position":1,"cik":"0002109966","reported_name":"Cao Sean Wuxiong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Bus. Development Officer"}}],"security":"Restricted Share Units","published_at":"2026-09-08T21:51:01.000Z","date":"2026-09-03","kind":"exercise","planned":false,"acquired":false,"shares":102233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On September 3, 2025, the Reporting Person was granted 408,933 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the third day of each third month."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On September 3, 2025, the Reporting Person was granted 408,933 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the third day of each third month."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."}],"balance_after":306700,"derivative":{"underlying":"Ordinary Shares","underlying_shares":102233},"source":{"system":"sec-edgar","filing":"0002109966-26-000006","document":"form4-09082026_090957.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2109966/000210996626000006/form4-09082026_090957.xml","form_type":"4"}},{"id":3570570,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":35580,"kind":"person","name":"Cao Sean Wuxiong","position":1,"cik":"0002109966","reported_name":"Cao Sean Wuxiong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Bus. Development Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-08T21:51:01.000Z","date":"2026-09-03","kind":"exercise","planned":false,"acquired":true,"shares":104236,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F4","text":"Reported securities are represented by 45,320 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."}],"balance_after":374445,"source":{"system":"sec-edgar","filing":"0002109966-26-000006","document":"form4-09082026_090957.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2109966/000210996626000006/form4-09082026_090957.xml","form_type":"4"}},{"id":3570569,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":35580,"kind":"person","name":"Cao Sean Wuxiong","position":1,"cik":"0002109966","reported_name":"Cao Sean Wuxiong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Bus. Development Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-08T21:51:01.000Z","date":"2026-09-03","kind":"exercise","planned":false,"acquired":true,"shares":235136,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reported securities are represented by 102,233 ADSs"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."}],"balance_after":270209,"source":{"system":"sec-edgar","filing":"0002109966-26-000006","document":"form4-09082026_090957.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2109966/000210996626000006/form4-09082026_090957.xml","form_type":"4"}},{"id":727250,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":35580,"kind":"person","name":"Cao Sean Wuxiong","position":1,"cik":"0002109966","reported_name":"Cao Sean Wuxiong","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Bus. Development Officer"}}],"security":"2025 Employee Share Option (right to buy)","published_at":"2026-06-24T23:22:27.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":181290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Number of underlying securities and exercise price expressed in terms of ADSs."},{"field":"shares","element":"transactionShares","label":"F2","text":"Number of underlying securities and exercise price expressed in terms of ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests, if at all, in eight equal quarterly installments following the date on which the 30-trading-day weighted average price of the Issuer's ADS (based on trading days only) is at or above US$8.00."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F4","text":"The Ordinary Shares may be represented by ADSs. Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Number of underlying securities and exercise price expressed in terms of ADSs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Number of underlying securities and exercise price expressed in terms of ADSs."}],"balance_after":181290,"derivative":{"exercise_price":1.53,"expiration_date":"2036-06-22","underlying":"Ordinary Shares","underlying_shares":181290},"source":{"system":"sec-edgar","filing":"0002109966-26-000004","document":"form4-06242026_110623.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000210996626000004/form4-06242026_110623.xml","form_type":"4"}},{"id":727249,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":35580,"kind":"person","name":"Cao Sean Wuxiong","position":1,"cik":"0002109966","reported_name":"Cao Sean Wuxiong","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Bus. Development Officer"}}],"security":"Restricted Share Units","published_at":"2026-06-24T23:22:27.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":181280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one American Depositary Shares (\"ADS\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Number of underlying securities and exercise price expressed in terms of ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest over four years, with one-fourth vesting on September 3, 2026 and the balance vesting ratably over the subsequent 12 quarters on the third day of each third month."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest over four years, with one-fourth vesting on September 3, 2026 and the balance vesting ratably over the subsequent 12 quarters on the third day of each third month."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F4","text":"The Ordinary Shares may be represented by ADSs. Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Number of underlying securities and exercise price expressed in terms of ADSs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Number of underlying securities and exercise price expressed in terms of ADSs."}],"balance_after":181280,"derivative":{"underlying":"Ordinary Shares","underlying_shares":181280},"source":{"system":"sec-edgar","filing":"0002109966-26-000004","document":"form4-06242026_110623.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000210996626000004/form4-06242026_110623.xml","form_type":"4"}},{"id":774269,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":35580,"kind":"person","name":"Cao Sean Wuxiong","position":1,"cik":"0002109966","reported_name":"Cao Sean Wuxiong","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Ordinary Shares","published_at":"2026-05-18T20:05:10.000Z","date":"2026-05-14","kind":"sale","planned":false,"acquired":false,"shares":21399,"price":1.99,"value":42584.01,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person sold 9,304 ADSs representing approximately 21,399 ordinary shares in connection with the partial vesting of a restricted stock unit award on January 31, 2026, solely to satisfy tax withholding obligations incurred in connection with the vesting."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Price expressed in terms of ADSs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The reported securities are represented by 15,249 ADSs."}],"balance_after":35073,"source":{"system":"sec-edgar","filing":"0001193125-26-228889","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000119312526228889/ownership.xml","form_type":"4"}}]}